- By insider
CFO of Coherus Biosciences Inc (30-Year Financial, Insider Trades) Jean-frederic Viret (insider trades) sold 46,144 shares of CHRS on 01/25/2021 at an average price of $19.95 a share. The total sale was $920,573.
Coherus BioSciences Inc is a biotechnology company that develops biosimilar therapeutics. The company seeks to ensure successful drug development and manufacturing under very aggressive timelines. Coherus BioSciences Inc has a market cap of $1.54 billion; its shares were traded at around $21.390000 with a P/E ratio of 10.48 and P/S ratio of 3.52. GuruFocus has detected 3 severe warning signs with Coherus BioSciences Inc. .
CFO Recent Trades:
-
CFO Jean-frederic Viret sold 46,144 shares of CHRS stock on 01/25/2021 at the average price of $19.95. The price of the stock has increased by 7.22% since.
Directors and Officers Recent Trades:
-
COO Vincent R Anicetti sold 2,500 shares of CHRS stock on 01/19/2021 at the average price of $17.94. The price of the stock has increased by 19.23% since.
For the complete insider trading history of CHRS, click here
.This article first appeared on GuruFocus.